Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Indivior loses appeal to block generic Suboxone opioid treatments

A divided federal appeals court ruled against Indivior’s bid to stop Dr. Reddy’s Laboratories and Alvogen from selling generic versions of the London-based company’s Suboxone film that infringed the opioid addiction treatment’s patents.

Read More »

Reckitt Benckiser Settles Indivior Opioid Investigation

Reckitt Benckiser Group agreed to pay $1.4 billion to settle a U.S. investigation into the sales and marketing of Suboxone Film, a product managed by the spinout company Indivior.

Read More »

FDA Issues Warnings to Companies Illegally Selling Drugs Containing Kratom

The FDA issued warning letters to two companies for illegally selling unapproved drug products that contain the herbal extract kratom.

Read More »

WHO Removes Controversial Opioid Guidelines Following Scathing Congressional Report

After accusations of being influenced by Purdue Pharma, the World Health Organization (WHO) withdrew two guidelines for opioid medications following criticism from U.S. lawmakers.

Read More »

Insys to pay $225 million, plead guilty in U.S. over opioid kickbacks

Insys Therapeutics Inc. agreed to pay $225 million and an operating unit will plead guilty to fraud to settle probes into their payment of kickbacks to induce doctors to prescribe highly addictive opioids, the U.S. Department of Justice said.

Read More »

U.S. charges pummel drugmaker Indivior, hurt Reckitt

Indivior Plc lost three-quarters of the company’s stock market value and former parent Reckitt Benckiser also fell after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the blockbuster opioid addiction treatment Suboxone.

Read More »

Major study debunks healthy moderate drinking myth

Blood pressure and stroke risk rise steadily the more alcohol people drink, and previous claims that one or two drinks a day might protect against stroke are not true, according to a genetic study.

Read More »

Advocacy Group and FDA Advisor Call for a Moratorium on Opioid Approvals

As America continues to grapple with the opioid crisis, nonprofit advocacy group Public Citizen is calling for the U.S. Food and Drug Administration (FDA) to place a moratorium on the approval of any new opioid medications.

Read More »

Indivior launches generic version of own opioid drug

Indivior launched a copycat version of the opioid addiction drug Suboxone in the U.S., one day after a court decision cleared the way for rivals to market generic forms of the blockbuster medicine.

Read More »

U.S. top court rejects bid to block Indivior opioid drug copycat

The U.S. Supreme Court dealt a blow to Indivior Plc on Tuesday, clearing the way for a copycat version of the British pharmaceutical firm’s lucrative opioid addiction treatment Suboxone Film in a victory for India-based generic drug maker Dr. Reddy’s Laboratories Ltd.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom